Some genes are expressed differently in earlier and later generations
of most cell lines. Many diseases become clinically expressed only lat
er in life, and show clustering of the age at onset in the affected si
blings, which may be related to the changing expression with age of th
e genes involved. Because insulin and its receptor are extremely ancie
nt and well preserved structures with almost universal mitogenic effec
ts, insulin may serve a paradigm of this process. It is suggested that
by stimulating cell proliferation, hyperinsulinemia speeds up the app
earance of later generations of cells with different expression of the
genes. Insulin resistance, accompanying any hyperinsulinemia and cons
idered to be a pathogenetic factor of some common later-age diseases,
involves only some biochemical, but not mitogenic effects of the hormo
ne. In humans, high levels of insulin in blood are encountered both ph
ysiologically after meals and in many pathological conditions: insulin
therapy inevitably causes peripheral hyperinsulinemia; in type 2 diab
etes hyperinsulinemia precedes hyperglycemia by many years; hyperinsul
inemia is an independent risk factor of atherosclerosis, of type 2 dia
betes itself, of some forms of dementia and other diseases; obesity is
an obligatory hyperinsulinemic condition. The opposite of hyperalimen
tation, i.e. calorie restriction (at least, in rodents) may exert its
life-prolonging effects through decreasing insulinemia and therefore t
he rate of cell proliferation. Insulin is only one example, and differ
ent mitogens regulate proliferation of different cells. It is likely t
hat growth factors in general accelerating the replication of cells, p
lay a role in speeding up the appearance of later-age diseases involvi
ng these cells. (C) 1998 Elsevier Science Ireland Ltd. All rights rese
rved.